Cubist Systematic Strategies, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2023$911
-99.9%
58
-99.9%
0.00%
-100.0%
Q1 2023$1,478,256
+52.4%
89,700
+44.2%
0.01%
+50.0%
Q4 2022$970,148
+154.0%
62,189
+111.3%
0.01%
+200.0%
Q3 2022$382,000
-75.8%
29,432
-73.8%
0.00%
-80.0%
Q2 2022$1,579,000
+78.6%
112,442
+82.1%
0.01%
+42.9%
Q1 2022$884,000
-59.7%
61,741
-61.6%
0.01%
-66.7%
Q4 2021$2,191,000
+245.6%
160,736
+315.3%
0.02%
+162.5%
Q3 2021$634,000
-39.8%
38,704
-38.2%
0.01%
-33.3%
Q2 2021$1,053,000
-59.7%
62,590
-56.3%
0.01%
-63.6%
Q1 2021$2,616,000
+209.2%
143,247
+208.2%
0.03%
+175.0%
Q4 2020$846,000
-21.4%
46,476
-23.0%
0.01%
-25.0%
Q3 2020$1,077,000
-30.6%
60,378
-30.2%
0.02%
-40.7%
Q2 2020$1,552,000
+211.0%
86,554
+163.4%
0.03%
+107.7%
Q1 2020$499,000
-38.3%
32,859
-19.9%
0.01%
-13.3%
Q4 2019$809,000
+591.5%
41,007
+504.2%
0.02%
+650.0%
Q3 2019$117,000
-86.0%
6,787
-85.6%
0.00%
-86.7%
Q2 2019$833,000
-22.1%
47,061
-10.3%
0.02%
-57.1%
Q1 2019$1,069,00052,4840.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders